FDA

Prenetics' ACT Genomics Profiling Test for Solid Tumors Receives FDA Clearance

FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek

FDA Approves Foundation Medicine Assay as CDx for Certain NSCLC Therapies

FDA Updates Xeloda Labeling to Make DPYD Variant Risks More Explicit

FDA Approves Mirati's Krazati for Advanced KRAS-Mutated Lung Cancer 

FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy

Novartis to Seek Pluvicto Approval in Another Advanced PSMA-Positive Prostate Cancer Setting

FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML

Genentech to Withdraw First-Line Tecentriq Bladder Cancer Indication

Legend Biotech to Launch CAR T-Cell Therapy Trial for Small Cell Lung Cancer, Neuroendocrine Tumors

Clarity Pharmaceuticals to Evaluate GRPr-Targeting Radiopharmaceutical in mCRPC Trial

Takeda to Discuss Positive Phase III Iclusig Data in Upfront ALL With Regulators

FDA Approves ImmunoGen's Elahere for Folate Receptor Alpha-Positive Ovarian Cancer

J Ints Bio to Begin US Trial of JIN-A02 for EGFR C797S-Mutated NSCLC

In Brief This Week: Omega Therapeutics, Rain Therapeutics, Oncoshot

AbbVie, Genmab File for Bispecific Antibody Approval in US, EU for CD20-Positive Advanced Lymphoma

In Brief This Week: Caris Life Sciences, Radiopharm Theranostics, Tempus